Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Epidemiological Parameters of Multiple Sclerosis in Chaharmahal and Bakhtiari Province, Iran Publisher



Omrani MA1 ; Bayati A2 ; Sahraian MA1 ; Eskandarieh S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Neurology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

Source: Current Journal of Neurology Published:2023


Abstract

Background: Multiple sclerosis (MS) is a neurological disease with a high burden and disability. There are reports of various medications’ side effects on patients with MS. The aim of the study is to determine the characteristics and medicine usage distribution among patients with MS in Chaharmahal and Bakhtiari Province in Iran. Methods: This registry-based cross-sectional study was performed among MS cases in Chaharmahal and Bakhtiari Province. The epidemiological data were collected from the nationwide MS registry of Iran (NMSRI) from 2019 to 2022. The information collected included age, sex, family history, type of MS, age at MS onset and diagnosis, MS symptoms, physical condition, and history of medication use. All tests were performed at a significance level of 0.05 using SPSS software. Results: A total of 416 patients included in this study. Among them, 325 individuals (78%) were women with mean ± standard deviation (SD) of age of 37.35 ± 8.51 years. No significant difference was observed between men and women in terms of age, type of MS disease, family history of MS, and physical condition (P > 0.05). The results showed that the Expanded Disability Status Scale (EDSS) score in female patients (1.41) was different from the EDSS score in male patients (1.77) (P < 0.05). Most of the patients often used interferon beta (IFN-β). Conclusion: The results provided new insight into the epidemiology and medicine patterns of patients with MS in Chaharmahal and Bakhtiari Province. The epidemiological situation of MS in this province is similar to other parts of Iran. Planning according to national programs is suggested for the management and control of MS. © 2023 Iranian Neurological Association, and Tehran University of Medical Sciences.
Other Related Docs
15. Cost-Utility Analysis of Multiple Sclerosis Rehabilitation in Iran, Expert Review of Pharmacoeconomics and Outcomes Research (2023)
21. Multiple Sclerosis Associated Risk Factors: A Case-Control Study, Iranian Journal of Public Health (2015)
25. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran, Iranian Journal of Public Health (2017)
26. The Prevalence of Multiple Sclerosis in Tehran, Iran, in 2020, Current Journal of Neurology (2023)
35. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2021)
41. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
47. Registry-Based Incidence of Multiple Sclerosis in Southwestern Iran, 2001-2014, Bangladesh Medical Research Council Bulletin (2016)
48. A Report of Multiple Sclerosis Registry in Mazandaran Province 2019-2021, Journal of Mazandaran University of Medical Sciences (2022)